Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C
Until HCV NS3/4A protease inhibitors become available at the end of 2011, the combination pegylated-interferon (PEG-IFN)-alfa and ribavirin (RBV) will remain the standard treatment for chronic hepatitis C patients. In some hepatitis C virus-infected patients, PEG-IFN plus RBV treatment against HCV s...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nepal Medical Association
2011-03-01
|
| Cyfres: | Journal of Nepal Medical Association |
| Mynediad Ar-lein: | http://jnma.com.np/jnma/index.php/jnma/article/view/44 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|